SUMMARY A retrospective study has been carried out on the necropsy material from 30 patients who have died after a clinically diagnosed myocardial infarction. This study has been undertaken to compare the reliability of the fluorescence of infarcted myocardium when stained by haematoxylin and eosin and an adjacent section stained by the haematoxylin basic fuchsin picric acid (HBFP) method to detect early ischaemia. The results showed that the fluorescence technique is reliable, reproducible and coincides with the findings obtained by HBFP stain.
The diagnosis of myocardial infarction of less than six hours duration by histological, histochemical or biochemical methods has always been subjective. Morphological changes in the myocardium less than six hours after the clinical event of infarction are minimal, making it impossible at light microscopic level, to assess the degree of irreversible damage that has taken place. Reviews of the histochemical investigations to demonstrate the changes in fat, glycogen, succinic dehydrogenase, cytochrome oxidase, phosphorylase, uridine A . _ * a ., , o B J~~F ig. 1 Haematoxylin and eosin stained section viewed by short wavelength blue light. The infarcted area is the light, almost white area, compared to the grey superficial zone (right side ofthe photograph) which are the unaffected muscle fibres. Fig. 2 An adjacent section to that illustrated in Fig. 1 , stained by haematoxylin basic fuchsin picric acid: the area ofinfarction is the dark zone. There is perfect correlation with the affected area in Fig. 1 It is important to ensure that all solutions are fresh and uncontaminated. Differentiation is completed when the red blood cells and collagen tissue in the section remain red whilst all other tissue components (other than ischaemic muscle) are yellow. If these parameters are not closely observed false positive or false negative results may be obtained. The decolouration of the red blood cells appears to be the most sensitive criterion.
The fluorescent examination was carried out on a Standard 14 Zeiss microscope fitted with an epifluorescence condenser model IV Fl, illuminated with a 12 V 100 W tungsten halogen light source and viewed with Neofluar objectives. The filters used were a primary filter of 440-490 nm and a dichromatic reflector of 510 nm and a barrier filter of 520 nm. With this microscope it is possible to switch from conventional substage lighting to the epifluorescence illumination thus allowing for the examination of both HBFP stained sections and the fluorescence of haematoxylin and eosin stained sections with the maximum correlation.
Results
The cases were divided into two groups based upon the clinical history and on the histological changes seen in the sections. In group I there were 14 cases with evidence of less than six hours of ischaemia. Group II consisted of 16 cases with a history of longer than six hours and up to 36 hours of ischaemia. In 28 of the cases the coronary arteries showed either complete occlusion of one or more of the major vessels or moderate to severe atherosclerotic changes. In two cases no vascular abnormalities were found.
The blocks for histological analysis were taken to comprise a complete cross section of both ventricles. In this way it was possible to relate the areas of infarction to the vessel pathology. The study was carried out by first examining the haematoxylin and eosin stained sections for fluorescence and mapping the positive areas. These areas were seen as bright yellow with clear-cut cell borders (Fig. 1) or yellow or red/brown with iUl-defined borders of the myocardial fibres. Analysing carefully and comparing group I with group II we found that the colour changes described above were not dependent on the duration of the ischaemia, or related to the patients age. Normally perfused myocardium was seen as dull olive green or red/brown with a clearly demarcated cell wall. The areas defined by fluorescence were then compared with the crimson red stained areas in the HBFP stained sections (Fig. 2) . It was found in all cases that they coincided exactly.
Discussion
The first six hours postinfarction are the most difficult to diagnose due to the lack of visible morphological change or reliable histochemistry. The HBFP stain has been reported to give a positive staining reaction 30 min after coronary occlusion and remain positive up to 36 h. This technique has hitherto been the only reasonably reliable method of demonstrating early ischaemic changes. The difficulties of differentiation have led some workers to experience false positive or false negative staining, although this can be largely overcome if our modifications are observed. Careful examination of these 30 cases of clinically proven myocardial infarction by the fluorescent technique has also proved to give consistent reliable results, with extremely good correlation with the HBFP method. Some time needs to be spent on known positive material to appreciate the sometimes subtle shades of fluorescence such as those between yellow to red/brown with hazy border (infarcted muscle) and, red/brown with a clearly demarcated border (normally perfused muscle), but no mistake can be made with the bright yellow fluorescence when it is present. Waviness as described by Bouchardy and Majno9 was observed in some of the cases of both groups. These areas were invariably positive by both techniques. However, in other instances the wave pattern was absent in positive areas. This suggests that the change of waviness is not always reliable as an indication of ischaemia. The animal experiments of Lie et a16 have shown that the HBFP method becomes positive after the first 30 min from occlusion. Whilst there are no animal studies to show exactly at which point the fluorescent method gives positive results, some of our patients had a clinical history of no more than 30 min from the onset of symptoms to death. These cases still gave unequivocally positive results.
It is concluded from our results that both haematoxylin and eosin fluorescence and the HBFP stain are reliable, reproducible methods of demonstrating early myocardial infarction.
